1951 Nobel Prize in Physiology or Medicine — Theiler and the Yellow Fever Vaccine

What You’ll Learn in This Article

You’ll understand how Max Theiler, a South Africa-born scientist who didn’t have a medical degree, created the attenuated yellow fever virus strain (17D) by repeatedly passing it through monkey brains and chicken embryos, and why this strain has remained the global standard vaccine for over 70 years.

Beyond Common Sense — Vaccines Aren’t Just “Dead Viruses”

We often imagine vaccines as “containing killed viruses.” This is true for only one type of vaccine (inactivated vaccines). There’s a much more powerful alternative: using live, but weakened, viruses. This is a live attenuated vaccine.

The idea of putting a live virus into the body seems dangerous at first. And it can be—if not done carefully, it can cause disease. However, if this risk can be precisely controlled, it can provide much stronger and longer-lasting immunity than inactivated vaccines. This is because the live virus replicates slightly within the body, strongly stimulating the immune system.

The question was: how to weaken the virus precisely? Theiler’s yellow fever vaccine was the first successful solution to this problem, and the method he developed became the prototype for other live attenuated vaccines, such as those for measles, mumps, rubella, and chickenpox.

In the language of computer science, attenuation is like a live patch. It’s about modifying the code of the original program (the wild-type virus) iteratively, fixing only the problematic parts to make the system harmless, without completely rewriting it. However, this live patch must maintain the desired properties (the ability to induce immunity).

The Zeitgeist — The Year Vaccines Became a Global Strategy

1951 was the year vaccines began to be integrated into the Cold War strategy. The Korean War was ongoing, and both the UN and communist forces were deploying large resources to combat infectious diseases. The WHO (founded in 1948) was expanding its early activities and preparing programs to control infectious diseases in tropical regions, with yellow fever being one of the first targets.

Yellow fever was a recurring cause of mass mortality in tropical cities in Africa and South America. It was transmitted by the Aedes aegypti mosquito. As cities grew, so did the mosquito population, and after the United States lost thousands of workers to the disease during the construction of the Panama Canal (1904-1914), international interest in the disease soared. However, a safe vaccine had been elusive.

The Nobel Committee’s decision to honor Theiler at this time reflected an acknowledgment of the establishment of the methodology of live attenuated vaccines. The Salk and Sabin polio vaccines, and the measles, mumps, and rubella (MMR) vaccine, would all be developed along this same line.

In the context of Korean history, 1951 was the year South Korean society faced a severe infectious disease crisis during the war. Typhus, scrub typhus, and dysentery were widespread, and the US Sanitary Corps and UNKRA (United Nations Korean Reconstruction Agency) conducted large-scale sanitation programs. At a time when the methodology of live attenuated vaccines was being established elsewhere in the world, South Korea faced a lack of infectious disease response infrastructure, intertwined with politics.

Theiler — A Nobel Prize Without a Degree

Max Theiler was born in Johannesburg, South Africa. His father, Arnold Theiler, was a renowned South African veterinarian and microbiologist, and this background influenced his son’s career path. He studied medicine at the University of St Andrews in Scotland, but did not complete his medical degree (M.D.) before moving to the United States, where he trained in tropical medicine at Harvard.

He then took a position at the New York Rockefeller Foundation, where he spent most of his life. The Rockefeller Foundation was a crucial hub for global infectious disease research at the time, with a particularly strong tropical medicine program. Theiler joined the yellow fever team within this program.

The fact that he did not hold a formal bachelor's or doctoral degree at the time of his Nobel Prize has been mentioned many times since. This does not mean that he lacked academic rigor, but rather that in the mid-20th century, many outstanding experimental scientists could participate in world-class research without a degree. This contrasts with the fact that this path is virtually impossible today.

The 17D Strain — The Magic of Repeated Passages

The Theiler team’s experiment was conceptually simple, but its execution involved extremely tedious repetition.

They started with the wild-type yellow fever virus (Asibi strain, isolated from a patient in Africa). They injected this strain into a monkey brain, and when the monkey became ill, they extracted the brain tissue and injected it into the next monkey. They repeated this process over several generations. Then, they switched the medium to mouse embryo tissue and repeated it. Finally, they switched the medium to chicken embryos and repeated it.

During each passage through the different media, the virus adapted to that medium. The virus that grew well in chicken embryos was selected, and its ability to infect humans and monkeys gradually weakened. This was a form of directed evolution.

The strain obtained through this process was 17D. The name comes from the 17th attempt (D series) in the lab notebook. 17D grows well in chicken embryos but does not cause disease in humans, while inducing nearly the same level of immunity as natural infection.

In the language of computer science, this is like a directed cycle of fuzz testing. It’s about applying iterative variations to an original program, while screening for the desired phenotype (maintenance of immunogenicity) and removing the undesired phenotype (pathogenicity). This approach allows natural selection to do the work, even if we don’t know the exact locations of the variations in advance.

One point where this analogy breaks down: software fuzz testing typically aims to find errors, while here, the goal is to remove errors (pathogenicity) and maintain the desired function. More accurately, it can be considered an early form of direct evolution. This approach would later become the standard methodology in industrial microbiology.

The Enduring Power of 17D

There is a reason why the 17D vaccine has remained in use to this day. Once administered, it provides lifelong immunity to most people. This is remarkable compared to most vaccines today, which require booster shots every few years.

Since the 1950s, the WHO has established programs to distribute this vaccine in yellow fever-endemic regions of Africa and South America, and today, tens of millions of people receive it each year. The population of areas that would not have been able to survive without this vaccine is considerable. A significant portion of the population growth in tropical regions in the latter half of the 20th century is a result of the era of this vaccine.

There are side effects. Very rarely, yellow fever vaccine-associated neurotropic disease (YEL-AND) and yellow fever vaccine-associated viscerotropic disease (YEL-AVD) occur. This is at a rate of approximately 1-2 cases per million doses. This is an inevitable risk of using live virus vaccines, but it is much lower than the risk of the disease itself, so it continues to be used. This trade-off is the essence of live vaccines.

Why It Matters

Theiler’s story leaves us with three key takeaways.

Scientifically, he established the methodology for developing live attenuated vaccines. Subsequently, vaccines for polio, measles, mumps, rubella, chickenpox, shingles, and rotavirus were all developed using the same approach. The theoretical roots of many of the vaccines we administer to children each year today lie in this methodology.

From a public health perspective, the 17D strain remains a single tool used for over 70 years. The exceptional durability of this vaccine has greatly increased the predictability of public health in tropical regions.

Philosophically, this story offers the insight that “controlled weakness can be a condition of strength.” Instead of completely eliminating a live threat, this approach involves precisely controlling the intensity of the threat in order to learn from it. This approach appears in various system reinforcement strategies, including chaos engineering, red team training, and controlled failure scenario learning.

His life, as a Nobel laureate without a degree, also leaves a lasting impression. His quiet laboratory life reminds us that formal academic paths are not the only path.

Theiler's 1951 Summary: He developed the attenuated yellow fever virus strain 17D by repeatedly passing the wild-type yellow fever virus through monkey brains, mouse embryos, and chicken embryos. This strain remains the global standard yellow fever vaccine today, and it became the prototype for the methodology of live attenuated vaccines.

→ Previous: 1950 — Henche, Kendal, and Reichstein → Next: 1952 — Waksman and Streptomycin